cGLRs as a Novel Family of PRRs: Comparison
Please note this is a comparison between Version 2 by Camila Xu and Version 1 by Vijay Kumar.

Pattern recognition receptors (PRRs) play critical roles in embryonic development, immune homeostasis, neurodevelopment, and neurodegeneration. PRRs are highly conserved germline-encoded proteins that recognize microbe/pathogen-associated molecular patterns (MAMPs or PAMPs) and death/damage-associated molecular patterns (DAMPs); thus, they regulate innate and adaptive immunity and contribute to the pathogenesis of many diseases ranging from infections to cancers.

  • PRRs
  • cGLRs
  • cGAS
  • STING
  • type 1 IFN

1. Introduction

Pattern recognition receptors (PRRs) play critical roles in embryonic development, immune homeostasis, neurodevelopment, and neurodegeneration. PRRs are highly conserved germline-encoded proteins that recognize microbe/pathogen-associated molecular patterns (MAMPs or PAMPs) and death/damage-associated molecular patterns (DAMPs) [1,2,3][1][2][3]; thus, they regulate innate and adaptive immunity [1,4,5][1][4][5] and contribute to the pathogenesis of many diseases ranging from infections to cancers [5,6,7,8,9,10,11][5][6][7][8][9][10][11]. Traditionally, PRR family members have included toll-like receptors (TLRs), C-type lectin receptors (CLRs), nucleotide-oligomerization domain (NOD)-like receptors (NLRs), absent in melanoma-2-like receptors (ALRs), retinoic acid-inducible gene (RIG)-1-like receptors (RLRs), C-type lectin receptors (CLRs), and different scavenger receptors (SRs) [2,9,12,13,14,15,16,17][2][9][12][13][14][15][16][17]. Cytosolic guanosine monophosphate (GMP)-adenosine monophosphate (AMP) synthase (cGAS)-like receptors (cGLRs) have been recently recognized as new PRRs that potentially interact with other PRRs to regulate immune homeostasis.

2. Emergence of cGLRs (Harboring cGAS and STING) as a Novel Family of PRRs

cGLRs have emerged or evolved as critical PRRs providing defense through different mechanisms in prokaryotes and eukaryotes, including humans. Table 1 shows different cGLRs and their known ligands. The first enzyme responsible for synthesizing cyclic guanosine monophosphate (GMP)-adenosine monophosphate (AMP) (cGAMP) or cyclicdinucleotides (CDNs), dinucleotide cyclase (DncV), or cGAS-DncV-like nucleotidyltransferase (CD-NTase), evolved in bacteria and has been reported in Vibrio cholerae. CD-NTases generating CDNs, like animal cGASs, are very diverse proteins numbering over 6000 to date [18]. In addition to producing CDNs, bacterial CD-NTases can also produce cyclic trinucleotides (CTNs) and linear oligonucleotides [19,20][19][20]. Although DncV lacks primary sequence homology to h-cGAS (synthesizes 2′3′-cGAMP), it synthesizes conventional 3′3′- cGAMP involved in bacterial chemotaxis [21,22][21][22]. Bacteria encode thousands of cGAS/DncV-like NTases (CD-NTases) to control their highly divergent anti-phage defense system. Furthermore, DncV NTases, cGAS homologs, and 2′-5′-oligoadenylate synthase 1 (OAS1, having aspartic acid (Asp) in place of E225) have five highly conserved active sites [22]. The CD-NTases of the cyclic oligonucleotide-based antiphage signaling system (CBASS, analogous to the cGAS/STING signaling pathway of metazoans) that are activated by the binding of a folded fragment of RNA share distant homology with the cGAS [23,24,25,26,27][23][24][25][26][27]. Furthermore, CBASS-activating bacteriophage RNA (cabRNA), via binding to the surface of positively charged CdnEO3 cyclase (a bacterial cGAS), promotes cGAMP synthesis to activate the CBASS-mediated immune response [28].Thus, the CBASS in the bacteria producing cGAMP serves as a defense system against bacteriophages [29]. The bacterial cGAS or CBASS comprises a four-gene operon that encodes bacterial cGAS, which is associated with phospholipase, two enzymes with the eukaryotic-like domains E1 and E2, and a Janus kinase-binding protein (JAB) domain, which provides resistance against several bacteriophages. cGAMP production activates phospholipases to disintegrate membranes and bacterial cell death before the completion of the bacteriophage life cycle or the production of mature bacteriophage [29].
Table 1. Different cGLRs (including mammalian cGAS), their ligands, cleaved products (cyclic dinucleotides, and CDNs such as 2′3′-cGAMP and/or 3′3′-cGAMP) activating STING and downstream signaling molecules throughout the animal kingdom from metazoans to mammals. Kindly see the article text and referenced articles for details.

References

  1. Li, D.; Wu, M. Pattern recognition receptors in health and diseases. Signal Transduct. Target. Ther. 2021, 6, 291.
  2. Kawai, T.; Akira, S. The role of pattern-recognition receptors in innate immunity: Update on Toll-like receptors. Nat. Immunol. 2010, 11, 373–384.
  3. Gong, T.; Liu, L.; Jiang, W.; Zhou, R. DAMP-sensing receptors in sterile inflammation and inflammatory diseases. Nat. Rev. Immunol. 2020, 20, 95–112.
  4. Kumar, V. Toll-Like Receptors in Adaptive Immunity. Handb. Exp. Pharmacol. 2022, 276, 95–131.
  5. Kumar, V.; Barrett, J.E. Toll-Like Receptors (TLRs) in Health and Disease: An Overview. Handb. Exp. Pharmacol. 2022, 276, 1–21.
  6. Kumar, V. Toll-like receptors in the pathogenesis of neuroinflammation. J. Neuroimmunol. 2019, 332, 16–30.
  7. Kumar, V. Toll-like receptors in immunity and inflammatory diseases: Past, present, and future. Int. Immunopharmacol. 2018, 59, 391–412.
  8. Sharma, N.; Saxena, S.; Agrawal, I.; Singh, S.; Srinivasan, V.; Arvind, S.; Epari, S.; Paul, S.; Jha, S. Differential Expression Profile of NLRs and AIM2 in Glioma and Implications for NLRP12 in Glioblastoma. Sci. Rep. 2019, 9, 8480.
  9. Chou, W.-C.; Jha, S.; Linhoff, M.W.; Ting, J.P.Y. The NLR gene family: From discovery to present day. Nat. Rev. Immunol. 2023, 23, 635–654.
  10. Duxbury, Z.; Wu, C.-h.; Ding, P. A Comparative Overview of the Intracellular Guardians of Plants and Animals: NLRs in Innate Immunity and Beyond. Annu. Rev. Plant Biol. 2021, 72, 155–184.
  11. Van Gorp, H.; Kuchmiy, A.; Van Hauwermeiren, F.; Lamkanfi, M. NOD-like receptors interfacing the immune and reproductive systems. FEBS J. 2014, 281, 4568–4582.
  12. Brown, G.D.; Willment, J.A.; Whitehead, L. C-type lectins in immunity and homeostasis. Nat. Rev. Immunol. 2018, 18, 374–389.
  13. Rehwinkel, J.; Gack, M.U. RIG-I-like receptors: Their regulation and roles in RNA sensing. Nat. Rev. Immunol. 2020, 20, 537–551.
  14. Loo, Y.M.; Gale, M., Jr. Immune signaling by RIG-I-like receptors. Immunity 2011, 34, 680–692.
  15. Davis, B.K.; Wen, H.; Ting, J.P. The inflammasome NLRs in immunity, inflammation, and associated diseases. Annu. Rev. Immunol. 2011, 29, 707–735.
  16. Kumar, V. Inflammation research sails through the sea of immunology to reach immunometabolism. Int. Immunopharmacol. 2019, 73, 128–145.
  17. Canton, J.; Neculai, D.; Grinstein, S. Scavenger receptors in homeostasis and immunity. Nat. Rev. Immunol. 2013, 13, 621–634.
  18. Culbertson, E.M.; Levin, T.C. Eukaryotic CD-NTase, STING, and viperin proteins evolved via domain shuffling, horizontal transfer, and ancient inheritance from prokaryotes. PLoS Biol. 2023, 21, e3002436.
  19. Whiteley, A.T.; Eaglesham, J.B.; de Oliveira Mann, C.C.; Morehouse, B.R.; Lowey, B.; Nieminen, E.A.; Danilchanka, O.; King, D.S.; Lee, A.S.Y.; Mekalanos, J.J.; et al. Bacterial cGAS-like enzymes synthesize diverse nucleotide signals. Nature 2019, 567, 194–199.
  20. Govande, A.A.; Duncan-Lowey, B.; Eaglesham, J.B.; Whiteley, A.T.; Kranzusch, P.J. Molecular basis of CD-NTase nucleotide selection in CBASS anti-phage defense. Cell Rep. 2021, 35, 109206.
  21. Davies, B.W.; Bogard, R.W.; Young, T.S.; Mekalanos, J.J. Coordinated regulation of accessory genetic elements produces cyclic di-nucleotides for V. cholerae virulence. Cell 2012, 149, 358–370.
  22. Wu, X.; Wu, F.H.; Wang, X.; Wang, L.; Siedow, J.N.; Zhang, W.; Pei, Z.M. Molecular evolutionary and structural analysis of the cytosolic DNA sensor cGAS and STING. Nucleic Acids Res. 2014, 42, 8243–8257.
  23. Morehouse, B.R.; Govande, A.A.; Millman, A.; Keszei, A.F.A.; Lowey, B.; Ofir, G.; Shao, S.; Sorek, R.; Kranzusch, P.J. STING cyclic dinucleotide sensing originated in bacteria. Nature 2020, 586, 429–433.
  24. Li, Y.; Slavik, K.M.; Toyoda, H.C.; Morehouse, B.R.; de Oliveira Mann, C.C.; Elek, A.; Levy, S.; Wang, Z.; Mears, K.S.; Liu, J.; et al. cGLRs are a diverse family of pattern recognition receptors in innate immunity. Cell 2023, 186, 3261–3276.e20.
  25. Millman, A.; Melamed, S.; Amitai, G.; Sorek, R. Diversity and classification of cyclic-oligonucleotide-based anti-phage signalling systems. Nat. Microbiol. 2020, 5, 1608–1615.
  26. Burdette, D.L.; Monroe, K.M.; Sotelo-Troha, K.; Iwig, J.S.; Eckert, B.; Hyodo, M.; Hayakawa, Y.; Vance, R.E. STING is a direct innate immune sensor of cyclic di-GMP. Nature 2011, 478, 515–518.
  27. Sun, L.; Wu, J.; Du, F.; Chen, X.; Chen, Z.J. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 2013, 339, 786–791.
  28. Banh, D.V.; Roberts, C.G.; Morales-Amador, A.; Berryhill, B.A.; Chaudhry, W.; Levin, B.R.; Brady, S.F.; Marraffini, L.A. Bacterial cGAS senses a viral RNA to initiate immunity. Nature 2023, 623, 1001–1008.
  29. Cohen, D.; Melamed, S.; Millman, A.; Shulman, G.; Oppenheimer-Shaanan, Y.; Kacen, A.; Doron, S.; Amitai, G.; Sorek, R. Cyclic GMP–AMP signalling protects bacteria against viral infection. Nature 2019, 574, 691–695.
  30. Kumar, V. The Trinity of cGAS, TLR9, and ALRs Guardians of the Cellular Galaxy against Host-Derived Self-DNA. Front. Immunol. 2021, 11, 624597.
  31. Chow, K.L.; Hall, D.H.; Emmons, S.W. The mab-21 gene of Caenorhabditis elegans encodes a novel protein required for choice of alternate cell fates. Development 1995, 121, 3615–3626.
  32. Li, S.; Yang, F.; Wang, F.; Lv, X.; Li, F. An invertebrate gene encoding a Mab21-containing protein involves in antiviral response through regulating the STING pathway. Dev. Comp. Immunol. 2021, 121, 104101.
  33. Hornung, V.; Hartmann, R.; Ablasser, A.; Hopfner, K.-P. OAS proteins and cGAS: Unifying concepts in sensing and responding to cytosolic nucleic acids. Nat. Rev. Immunol. 2014, 14, 521–528.
  34. Wang, Y.; Holleufer, A.; Gad, H.H.; Hartmann, R. Length dependent activation of OAS proteins by dsRNA. Cytokine 2020, 126, 154867.
  35. Kristiansen, H.; Gad, H.H.; Eskildsen-Larsen, S.; Despres, P.; Hartmann, R. The oligoadenylate synthetase family: An ancient protein family with multiple antiviral activities. J. Interferon Cytokine Res. 2011, 31, 41–47.
  36. Zhang, X.; Wu, J.; Du, F.; Xu, H.; Sun, L.; Chen, Z.; Brautigam, C.A.; Zhang, X.; Chen, Z.J. The Cytosolic DNA Sensor cGAS Forms an Oligomeric Complex with DNA and Undergoes Switch-like Conformational Changes in the Activation Loop. Cell Rep. 2014, 6, 421–430.
  37. Li, X.; Shu, C.; Yi, G.; Chaton, C.T.; Shelton, C.L.; Diao, J.; Zuo, X.; Kao, C.C.; Herr, A.B.; Li, P. Cyclic GMP-AMP Synthase Is Activated by Double-Stranded DNA-Induced Oligomerization. Immunity 2013, 39, 1019–1031.
  38. Huiting, E.; Cao, X.; Ren, J.; Athukoralage, J.S.; Luo, Z.; Silas, S.; An, N.; Carion, H.; Zhou, Y.; Fraser, J.S.; et al. Bacteriophages inhibit and evade cGAS-like immune function in bacteria. Cell 2023, 186, 864–876.e21.
  39. Eaglesham, J.B.; Kranzusch, P.J. Conserved strategies for pathogen evasion of cGAS-STING immunity. Curr. Opin. Immunol. 2020, 66, 27–34.
  40. Ahn, J.; Barber, G.N. STING signaling and host defense against microbial infection. Exp. Mol. Med. 2019, 51, 1–10.
  41. Burroughs, A.M.; Aravind, L. Identification of Uncharacterized Components of Prokaryotic Immune Systems and Their Diverse Eukaryotic Reformulations. J. Bacteriol. 2020, 202, e00365-20.
  42. Martin, M.; Hiroyasu, A.; Guzman, R.M.; Roberts, S.A.; Goodman, A.G. Analysis of Drosophila STING Reveals an Evolutionarily Conserved Antimicrobial Function. Cell Rep. 2018, 23, 3537–3550.e6.
  43. Zakovic, S.; Levashina, E.A. Insects Go on a STING Operation to Tackle Intracellular Invaders. Immunity 2018, 49, 195–197.
  44. Goto, A.; Okado, K.; Martins, N.; Cai, H.; Barbier, V.; Lamiable, O.; Troxler, L.; Santiago, E.; Kuhn, L.; Paik, D.; et al. The Kinase IKKβ Regulates a STING- and NF-κB-Dependent Antiviral Response Pathway in Drosophila. Immunity 2018, 49, 225–234.e4.
  45. Dostert, C.; Jouanguy, E.; Irving, P.; Troxler, L.; Galiana-Arnoux, D.; Hetru, C.; Hoffmann, J.A.; Imler, J.-L. The Jak-STAT signaling pathway is required but not sufficient for the antiviral response of drosophila. Nat. Immunol. 2005, 6, 946–953.
  46. Lamiable, O.; Kellenberger, C.; Kemp, C.; Troxler, L.; Pelte, N.; Boutros, M.; Marques, J.T.; Daeffler, L.; Hoffmann, J.A.; Roussel, A.; et al. Cytokine Diedel and a viral homologue suppress the IMD pathway in Drosophila. Proc. Natl. Acad. Sci. USA 2016, 113, 698–703.
  47. Slavik, K.M.; Morehouse, B.R.; Ragucci, A.E.; Zhou, W.; Ai, X.; Chen, Y.; Li, L.; Wei, Z.; Bähre, H.; König, M.; et al. cGAS-like receptors sense RNA and control 3′2′-cGAMP signalling in Drosophila. Nature 2021, 597, 109–113.
  48. Holleufer, A.; Winther, K.G.; Gad, H.H.; Ai, X.; Chen, Y.; Li, L.; Wei, Z.; Deng, H.; Liu, J.; Frederiksen, N.A.; et al. Two cGAS-like receptors induce antiviral immunity in Drosophila. Nature 2021, 597, 114–118.
  49. Moehlman, A.T.; Kanfer, G.; Youle, R.J. Loss of STING in parkin mutant flies suppresses muscle defects and mitochondria damage. PLoS Genet. 2023, 19, e1010828.
  50. O’Callaghan, B.; Hardy, J.; Plun-Favreau, H. PINK1: From Parkinson’s disease to mitophagy and back again. PLOS Biol. 2023, 21, e3002196.
  51. Pickrell, A.M.; Youle, R.J. The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson’s disease. Neuron 2015, 85, 257–273.
  52. Quinn, P.M.J.; Moreira, P.I.; Ambrósio, A.F.; Alves, C.H. PINK1/PARKIN signalling in neurodegeneration and neuroinflammation. Acta Neuropathol. Commun. 2020, 8, 189.
More
ScholarVision Creations